MX9102647A - Nueva proteina capaz de inducir una respuesta inmunoprotectora contra la infeccion causada por toxoplasma gondii y para clonar y expresar un gen que codifica a la proteina. - Google Patents
Nueva proteina capaz de inducir una respuesta inmunoprotectora contra la infeccion causada por toxoplasma gondii y para clonar y expresar un gen que codifica a la proteina.Info
- Publication number
- MX9102647A MX9102647A MX9102647A MX9102647A MX9102647A MX 9102647 A MX9102647 A MX 9102647A MX 9102647 A MX9102647 A MX 9102647A MX 9102647 A MX9102647 A MX 9102647A MX 9102647 A MX9102647 A MX 9102647A
- Authority
- MX
- Mexico
- Prior art keywords
- clone
- inducing
- express
- gene
- response against
- Prior art date
Links
- 241000223997 Toxoplasma gondii Species 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title 3
- 102000004169 proteins and genes Human genes 0.000 title 2
- 230000002480 immunoprotective effect Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000001262 western blot Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/45—Toxoplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se describe un antígeno purificado de T.gondii que tiene un peso molecular de 54kDa (como se determina mediante la prueba de manchado de Western), el cual es reactivo con los anticuerpos inducidos contra una proteína recombinante, obtenida mediante la expresión de una cADN de T.gondii definida (secuencia 1) en una célula del huésped; también se describen fragmentos inmunogénicos del antígeno de 54kDa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909027728A GB9027728D0 (en) | 1990-12-20 | 1990-12-20 | Novel protein |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9102647A true MX9102647A (es) | 1994-03-31 |
Family
ID=10687389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9102647A MX9102647A (es) | 1990-12-20 | 1991-12-18 | Nueva proteina capaz de inducir una respuesta inmunoprotectora contra la infeccion causada por toxoplasma gondii y para clonar y expresar un gen que codifica a la proteina. |
Country Status (14)
Country | Link |
---|---|
US (1) | US6077690A (es) |
EP (1) | EP0652956A1 (es) |
JP (1) | JPH06505865A (es) |
KR (2) | KR100250944B1 (es) |
AU (1) | AU661982B2 (es) |
CA (1) | CA2098845A1 (es) |
GB (1) | GB9027728D0 (es) |
IE (1) | IE914422A1 (es) |
MX (1) | MX9102647A (es) |
NZ (1) | NZ241043A (es) |
PT (1) | PT99842A (es) |
SG (1) | SG48325A1 (es) |
WO (1) | WO1992011366A1 (es) |
ZA (1) | ZA919982B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6172194A (en) * | 1993-02-08 | 1994-08-29 | Paravax, Inc. | Defective sindbis virus vectors that express (toxoplasma gondii) p30 antigens |
EP0695356A1 (en) * | 1993-04-30 | 1996-02-07 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |
ZA958366B (en) * | 1994-10-06 | 1996-04-24 | Akzo Nobel Nv | New toxoplasma gondii antigens |
GB9929434D0 (en) * | 1999-12-13 | 2000-02-09 | Smithkline Beecham Biolog | Novel vaccine composition |
JPWO2002017960A1 (ja) * | 2000-08-31 | 2004-12-09 | 中外製薬株式会社 | トキソプラズマ・ゴンディに対するワクチン |
CN101137674A (zh) | 2005-03-08 | 2008-03-05 | 肯顿有限公司 | 刚地弓形虫的嵌合重组抗原 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3940598A1 (de) * | 1989-12-08 | 1991-06-13 | Behringwerke Ag | Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung |
US4879213A (en) * | 1986-12-05 | 1989-11-07 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse |
FR2618680B1 (fr) * | 1987-07-31 | 1990-05-11 | Pasteur Institut | Antigenes d'excretion-secretion specifiques de toxoplasma gondii, leurs produits d'expression, leur procede d'obtention et leurs applications diagnostiques et prophylactiques |
US4877726A (en) * | 1988-03-02 | 1989-10-31 | Research Institute Of Palo Alto Medical Foundation | Method for the detection of acute-phase toxoplasma infection |
IL93883A (en) * | 1989-04-12 | 1993-02-21 | Iscar Ltd | Cutting insert for a milling cutting tool |
-
1990
- 1990-12-20 GB GB909027728A patent/GB9027728D0/en active Pending
-
1991
- 1991-11-06 ZA ZA919982A patent/ZA919982B/xx unknown
- 1991-12-16 JP JP4501657A patent/JPH06505865A/ja active Pending
- 1991-12-16 EP EP92901011A patent/EP0652956A1/en not_active Withdrawn
- 1991-12-16 AU AU90714/91A patent/AU661982B2/en not_active Expired
- 1991-12-16 CA CA002098845A patent/CA2098845A1/en not_active Abandoned
- 1991-12-16 KR KR1019930701891A patent/KR100250944B1/ko not_active IP Right Cessation
- 1991-12-16 SG SG1996008928A patent/SG48325A1/en unknown
- 1991-12-16 WO PCT/EP1991/002423 patent/WO1992011366A1/en not_active Application Discontinuation
- 1991-12-18 NZ NZ241043A patent/NZ241043A/xx not_active IP Right Cessation
- 1991-12-18 PT PT99842A patent/PT99842A/pt not_active Application Discontinuation
- 1991-12-18 IE IE442291A patent/IE914422A1/en not_active Application Discontinuation
- 1991-12-18 MX MX9102647A patent/MX9102647A/es unknown
-
1995
- 1995-06-02 US US08/458,922 patent/US6077690A/en not_active Expired - Lifetime
-
1999
- 1999-10-29 KR KR1019997010057A patent/KR100260998B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE914422A1 (en) | 1992-07-01 |
CA2098845A1 (en) | 1992-06-21 |
KR100260998B1 (en) | 2000-06-15 |
NZ241043A (en) | 1993-09-27 |
KR930703445A (ko) | 1993-11-30 |
GB9027728D0 (en) | 1991-02-13 |
SG48325A1 (en) | 1998-04-17 |
AU661982B2 (en) | 1995-08-17 |
EP0652956A1 (en) | 1995-05-17 |
AU9071491A (en) | 1992-07-22 |
PT99842A (pt) | 1992-12-31 |
ZA919982B (en) | 1992-12-30 |
US6077690A (en) | 2000-06-20 |
JPH06505865A (ja) | 1994-07-07 |
WO1992011366A1 (en) | 1992-07-09 |
KR100250944B1 (ko) | 2000-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE258188T1 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge | |
CY1106635T1 (el) | Ανοσοενισχυτικο που περιεχει ν - φορμυλο μεθειονυλο-πεπτιδια για εμβολια | |
ES2046462T3 (es) | Marcadores de activacion de celulas "t". | |
BR0113921A (pt) | ácidos nucléicos e polipeptìdeos receptores | |
BR9708387A (pt) | Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada. | |
ES2165851T3 (es) | Proteinas multivalentes que se unen a antigenos. | |
ES2161817T3 (es) | Antigenos de toxoplasma gondii, su preparacion y su utilizacion. | |
DE69831594D1 (de) | Intakte oder zerstörte insektenzellen als antigenadjuvant | |
CY1109439T1 (el) | Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους | |
DK53687A (da) | Peptid_fra htlv-iii-viruskappeprotein | |
BR9500732B8 (pt) | Kit diagnóstico para a detecção de anticorpos contra vírus que causam imunodeficiência. | |
ES2062330T3 (es) | Conjugados. | |
ES2123558T3 (es) | Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc. | |
ATE172249T1 (de) | Monoklonale antikörper gegen katzen-t- lymphotropes lentivirus | |
KR860004146A (ko) | 경구용 백신의 제조방법 | |
ATE90388T1 (de) | Schuetzendes peptid-antigen. | |
MX9102647A (es) | Nueva proteina capaz de inducir una respuesta inmunoprotectora contra la infeccion causada por toxoplasma gondii y para clonar y expresar un gen que codifica a la proteina. | |
KR940003566A (ko) | 재조합 아데노바이러스 백신 | |
DE69123970D1 (de) | Ehv-4 glykoprotein vazin | |
ES2118720T3 (es) | Produccion y utilizacion de agentes antihelminticos e inmunogenos protectores. | |
ES2125236T3 (es) | Mejoras relativas a la deteccion de virus. | |
MY102593A (en) | Antigents of plasmodium falciparum | |
FI915649A0 (fi) | Cystein tiol-skyddade peptider foer anvaendning vid immunologiska bestaemningar. | |
ES2037795T3 (es) | Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2. | |
DK0439601T3 (da) | Præparat indeholdende en B-epitop fra kappe- glycoproteinet fra et retrovirus og en T-epitop fra et protein, der er forskelligt fra dette retrovirus |